At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 16 enrolled
Drug / intervention
BI 425809 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Investigate the Effects of Memantine on the Pharmacokinetics of BI 425809 and Vice Versa in Healthy Male and Female Subjects (Non-randomized, Single-arm, Open-label, Three-period, One Fixed Sequence Cross-over Study)
In Brief
A Phase 1 clinical trial evaluating BI 425809 and Memantine for Healthy. Completed, enrolled 16 participants across 1 site.
Detailed Summary
Investigate the effect of steady state exposures of memantine on the steady-state pharmacokinetics of BI 425809 and vice versa in healthy subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
First PostedJun 2019
Enrollment StartJul 2019
Primary CompletionOct 2019
TodayJul 2026
First PostedJun 17, 2019
Enrollment StartJul 17, 2019
Primary CompletionOct 30, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.0 years ago
Interventions
BI 425809drug
Film coated tablet
Memantinedrug
Film coated tablet